Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Goodrich, Erica L
96  Ergebnisse:
Personensuche X
?
1

Response to Mei et al. regarding the incidence and predicto..:

Freedman, Benjamin L. ; Berg, David D. ; Scirica, Benjamin M....
Clinical Cardiology.  46 (2023)  3 - p. 348-349 , 2023
Link: https://doi.org/10.1002/..
 
?
2

Multi-marker risk assessment in patients hospitalized with ..:

Bhatt, Ankeet S. ; Daniels, Lori B. ; de Lemos, James...
American Heart Journal.  258 (2023)  - p. 149-156 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Epidemiology of heart failure hospitalization in patients w..:

Freedman, Benjamin L. ; Berg, David D. ; Scirica, Benjamin M....
Clinical Cardiology.  45 (2022)  8 - p. 831-838 , 2022
Link: https://doi.org/10.1002/..
 
?
4

Epidemiology and Management of ST‐Segment–Elevation Myocard..:

Bhatt, Ankeet S. ; Varshney, Anubodh S. ; Goodrich, Erica L....
Journal of the American Heart Association.  11 (2022)  9 - p. , 2022
Link: https://doi.org/10.1161/..
 
?
5

Cardiovascular Biomarkers and Heart Failure Risk in Stable ..:

Berg, David D. ; Freedman, Benjamin L. ; Bonaca, Marc P....
Journal of the American Heart Association.  10 (2021)  9 - p. , 2021
Link: https://doi.org/10.1161/..
 
?
6

Efficacy and Safety of Vorapaxar by Intensity of Background..:

Gilchrist Jr, Ian C. ; Morrow, David A. ; Creager, Mark A....
Journal of the American Heart Association.  10 (2021)  20 - p. , 2021
Link: https://doi.org/10.1161/..
 
?
7

Relationship between baseline cardiac biomarkers and cardio..:

Zelniker, Thomas A. ; Morrow, David A. ; Mosenzon, Ofri...
European Journal of Heart Failure.  23 (2020)  6 - p. 1026-1036 , 2020
Link: https://doi.org/10.1002/..
 
?
8

Cardiorenal outcomes with dapagliflozin by baseline glucose..:

Cahn, Avivit ; Wiviott, Stephen D. ; Mosenzon, Ofri...
Diabetes, Obesity and Metabolism.  23 (2020)  1 - p. 29-38 , 2020
Link: https://doi.org/10.1111/..
 
?
9

Plasma ceramide and phospholipid-based risk score and the r..:

Gencer, Baris ; Morrow, David A ; Braunwald, Eugene...
European Journal of Preventive Cardiology.  29 (2020)  6 - p. 895-902 , 2020
Link: https://doi.org/10.1093/..
 
?
10

Vorapaxar for secondary prevention in the elderly with peri..:

Patel, Siddharth M ; Morrow, David A ; Kidd, Stephen K...
Vascular Medicine.  24 (2019)  2 - p. 159-161 , 2019
Link: https://doi.org/10.1177/..
 
?
11

Efficacy and safety of vorapaxar for secondary prevention i..:

Xu, Haiyan ; Bonaca, Marc P ; Goodrich, Erica..
European Heart Journal. Acute Cardiovascular Care.  10 (2019)  2 - p. 190-199 , 2019
Link: https://doi.org/10.1177/..
 
?
12

SGLT2 inhibitors for primary and secondary prevention of ca..:

Zelniker, Thomas A ; Wiviott, Stephen D ; Raz, Itamar...
The Lancet.  393 (2019)  10166 - p. 31-39 , 2019
Link: https://doi.org/10.1016/..
 
?
13

Efficacy and safety of more potent antiplatelet therapy wit..:

Correa, Simon ; Bonaca, Marc P. ; Scirica, Benjamin M....
Journal of Thrombosis and Thrombolysis.  47 (2018)  3 - p. 353-360 , 2018
Link: https://doi.org/10.1007/..
 
?
14

Metabolic syndrome and the risk of adverse cardiovascular e..:

Cavallari, Ilaria ; Cannon, Christopher P ; Braunwald, Eugene...
European Journal of Preventive Cardiology.  25 (2018)  8 - p. 830-838 , 2018
Link: https://doi.org/10.1177/..
 
?
15

Cystatin C for Risk Stratification in Patients After an Acu..:

Correa, Simon ; Morrow, David A. ; Braunwald, Eugene...
Journal of the American Heart Association.  7 (2018)  20 - p. , 2018
Link: https://doi.org/10.1161/..
 
1-15